Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial

Authors

  • António Araújo Serviço de Oncologia Médica. Centro Hospitalar de Entre o Douro e Vouga. Santa Maria da Feira, & Instituto Português de Oncologia. Porto. Portugal.

DOI:

https://doi.org/10.20344/amp.4095

Abstract

Cancer has the potential to induce hypercoagulable states. On the other hand, venous thromboembolism may be the harbinger of an occult cancer, may represent a complication of known malignant disease or complicate hospitalization, surgery or various systemic treatments. The importance of venous thromboembolism in patients with cancer is often underestimated resulting in under-diagnosis, which may lead to significant morbidity and mortality. However, many cancer patients do not receive prophylaxis and suitable treatment for venous thromboembolism. The author make some considerations on this disease by addressing the interest and the objectives of the clinical trial CATCH and use of sodium tinzaparin.

Downloads

Download data is not yet available.

How to Cite

1.
Araújo A. Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial. Acta Med Port [Internet]. 2013 May 31 [cited 2024 Nov. 22];26(2):83-5. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/4095

Issue

Section

Perspective